Long‐term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin‐1 receptor antagonist) in patients with rheumatoid arthritis: Extension phase of a randomized, double‐blind, placebo‐controlled trial
Year: 2002
Type: article
Study design: Clinical Trial
Source: Arthritis & Rheumatism
DOI: 10.1002/art.10578
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: rheumatoid arthritis, interleukin-1 receptor antagonist, long-term efficacy, long-term safety, durability of response, ACR20 response, dose comparison, subcutaneous injection, skin reactions, adverse events, radiographic progression, treatment withdrawal, injection site reactions, rheumatoid factor, C-reactive protein
Open Access status: closed
OpenAlex ID: W2082067229
